How have developments in research, drug development, and management created new paradigms in the diagnosis and treatment of cancer and what this could mean for the future. Interviewees include:
Dr. Carlos Cordon-Cardo, a physician-scientist known widely for his research in experimental pathology and molecular oncology at the Icahn School of Medicine at Mount Sinai.
Brian Dranka, Ph.D., Manager of Biology, Agilent Cell Analysis Division.
Hans Christian Peterson, Director of Scientific Affairs at Dako, Agilent Pathology Solutions